Cytokind Inc.
Exeter, NH
- UEI
- ESXSVJEX6E33
- CAGE
- 8SF56
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 103 Front St, Exeter, NH 03833, USA
- Website
- cytokind.net
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$604,585 |
Contract awards
Quick answers
Is Cytokind Inc. registered in SAM.gov?
Yes. Cytokind Inc.'s SAM.gov registration is active through March 31, 2027.
What is Cytokind Inc.'s most recent federal award?
Cytokind Inc.'s most recent federal contract award is Cytokind: the overall objective of this contract is to provide clinical validation for the treatment of covid with… (75A50122C00064), from Office of the Assistant Secretary for Preparedness and Response, on September 19, 2022.
On GovTribe
See Cytokind Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors